Refractory Hodgkin lymphoma: time for targeted therapies?

被引：1
|
作者：
Brice, Pauline [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BLOOD | 2018年 / 131卷 / 11期
关键词：
BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE;
D O I：
10.1182/blood-2017-12-824136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
With the use of targeted therapies in classical Hodgkin lymphoma (HL), the paradigm of salvage chemotherapy followed by autotransplant may have changed. In this issue of Blood, Herrera et al report positive results using targeted therapy for salvage treatment before autotransplantation.(1)
引用
收藏
页码：1156 / 1157
页数：4
相关论文
共 50 条
  • [41] Transplant strategies in relapsed/refractory Hodgkin lymphoma
    Shah, Gunjan L.
    Moskowitz, Craig H.
    BLOOD, 2018, 131 (15) : 1689 - 1697
  • [42] Paraneoplastic refractory prurigos in a Hodgkin lymphoma patient
    Okamura, Ikue
    Tatara, Raine
    Ikeda, Takashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1179 - 1180
  • [43] Strategies for Management of Relapsed or Refractory Hodgkin Lymphoma
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 716 - 718
  • [44] Treatment of Patients WiT Refractory Hodgkin Lymphoma
    Basara, Nadezda
    Faber, Nikolai
    Menzel, Helge
    Drewniock, Petra
    Sitskaia, Xenia
    Lukic, Stefan
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 132 - 132
  • [45] Lenalidomide In Patients with Relapsed or Refractory Hodgkin Lymphoma
    Boll, Boris
    Fuchs, Michael
    Reiners, Katrin S.
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2010, 116 (21) : 1166 - 1167
  • [46] CURRENT STRATEGIES IN REFRACTORY OR RELAPSED HODGKIN LYMPHOMA
    von Tresckow, B.
    Borchmann, P.
    Fuchs, M.
    Pluetschow, A.
    Engert, A.
    HAEMATOLOGICA, 2010, 95 : S31 - S31
  • [47] Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma
    Yun Choi
    Catherine S. Diefenbach
    Current Oncology Reports, 2020, 22
  • [48] Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma
    Choi, Yun
    Diefenbach, Catherine S.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (01)
  • [49] Nivolumab experience in a patient with refractory Hodgkin lymphoma
    Karaman, S.
    Tugcu, D.
    Aydogdu, S.
    Karagenc, A.
    Dogan, O.
    Turkmen, A.
    Ocak, S.
    Tuna, R.
    Karakas, Z.
    LEUKEMIA RESEARCH, 2018, 73 : S65 - S65
  • [50] Management of Relapsed and Refractory Hodgkin Lymphoma in 2018
    Rutherford, Sarah C.
    Leonard, John P.
    JAMA ONCOLOGY, 2018, 4 (08) : 1120 - 1121
12345